Tag: Troubling

By iwano@_84

Coronavirus updates: Birx warns of ‘troubling signs’ in Northeast amid ‘very different’ spread of COVID-19

“What we did in the spring is not going to work in the fall,” Birx said.

A pandemic of the novel coronavirus has now killed more than 1 million people worldwide.

Over 36.7 million people across the globe have been diagnosed with COVID-19, the disease caused by the new respiratory virus, according to data compiled by the Center for Systems Science and Engineering at Johns Hopkins University. The criteria for diagnosis — through clinical means or a lab test — has varied from country-to-country. Still, the actual numbers are believed to be much higher due to testing shortages, many unreported cases and suspicions that some national governments are hiding or downplaying the scope of their outbreaks.

Read More
By iwano@_84

New York Worries Over 20 Coronavirus Hot Spots, Wisconsin Sees Troubling Trends | Top News

By Jonathan Allen and Lisa Shumaker

NEW YORK (Reuters) – New York state reported an uptick of positive coronavirus tests in 20 “hot spots” on Thursday, while Midwest states also reported rising caseloads led by Wisconsin, where U.S. President Donald Tramp will hold rallies over the weekend.

New cases of COVID-19 rose in 27 out of 50 U.S. states in September compared with August, with an increase of 111% in Wisconsin, according to a Reuters analysis.

Wisconsin is also dealing with a troubling rise in serious COVID-19 cases that threaten to overwhelm hospitals.

“Our emergency department has had several instances in the past week where it was past capacity and needed to place patients in beds in the hallways,” Bellin Health, which runs a hospital in Green Bay, said in a statement. “Our ICU (intensive care unit) beds have also been full, or nearly full, during the past week.”

Dr.

Read More
By iwano@_84

COVID Treatment’s Positive Test Results Contain Troubling Wrinkles Upon Examination

KEY POINTS

  • Regeneron’s COVID-19 monoclonal antibody cocktail performed well on safety and reduction of viral load
  • It was not, however, tested on hospitalized patients, and limitations on pricing and the production of monoclonal antibody treatments suggest it’s no panacea for the pandemic
  • Also concerning were its effects on actual symptom reduction, for which none of the groups produced a statistically significant effect

Positive results from trials are a hopeful step for a COVID-19 monoclonal antibody cocktail, but some elements of the data cast doubt on the efficacy and practicality of the treatment. The results, announced Tuesday by pharmaceutical company Regeneron, did suggest that their drug reduced viral loads and performed well on safety metrics.

“We are highly encouraged by the robust and consistent nature of these initial data, as well as the emerging well-tolerated safety profile, and we have begun discussing our findings with regulatory authorities while continuing our ongoing

Read More